1494 studies found for:    "Sexually Transmitted Diseases, Viral"
Show Display Options
Rank Status Study
21 Not yet recruiting Safety and Efficacy of Allogenic Adoptive Cell Therpy for Immune Reconstitution in Chronic HIV-1 Infected Patients
Conditions: Human Immunodeficiency Virus;   Disorder of Immune Reconstitution
Interventions: Other: Conventional plus AAC treatment;   Other: Conventional plus placebo treatment
22 Enrolling by invitation Improving Prognosis in HIV Infection
Condition: Human Immunodeficiency Virus
Intervention: Dietary Supplement: Probiotic compound
23 Not yet recruiting Community Intervention for HIV Testing & Care Linkage Among Young MSM in Bulgaria
Conditions: Acquired Immunodeficiency Syndrome;   HIV
Interventions: Behavioral: Social Network Leader Endorsement;   Behavioral: HIV Counseling
24 Recruiting The Compartmental Biology of HIV in the Male Genital Tract
Conditions: Human Immunodeficiency Virus;   Virus Shedding
Intervention:
25 Recruiting A Phase IV, Open Label, 4-period Cross-over Study to Investigate a Drug Interaction Between Lamivudine and Sorbitol Oral Solutions in Healthy Volunteers
Condition: Infection, Human Immunodeficiency Virus
Interventions: Drug: Lamivudine;   Drug: Sorbitol
26 Recruiting ART Drug Dosage Adjustment in HIV-infected Population
Condition: HIV Infections
Intervention: Drug: Tenofovir(TDF)+Lamivudine(3TC)+Efavirenz(EFV)
27 Recruiting Safety and Efficacy of MK-1439A in Participants Infected With Treatment-Naïve Human Immunodeficiency Virus (HIV) -1 With Transmitted Resistance (MK-1439A-030)
Condition: HIV-1 Infection
Intervention: Drug: MK-1439A
28 Recruiting Cardiometabolic Effects of Eplerenone in HIV Infection
Conditions: Cardiac Steatosis;   Hepatic Steatosis
Intervention: Drug: Inspra /Eplerenone
29 Recruiting Feasibility and Interest of a HIV Quarterly Preventive Global Care in Men Who Have Sex With Men in Sub-Saharan Africa
Condition: HIV Infection
Intervention: Other: HIV quarterly global care
30 Recruiting Inflammatory Pathogenesis of Coronary Atherosclerosis in HIV
Conditions: Coronary Artery Disease;   Human Immunodeficiency Virus
Interventions: Drug: Colchicine;   Drug: Placebo
31 Not yet recruiting Viral Suppression After Analytic Treatment Interruption in Thai Patients Who Initiated Highly Active Antiretroviral Therapy During Acute HIV Infection
Conditions: Acute HIV Infection;   Antiretroviral Treatment Interruption
Intervention: Other: Treatment interruption
32 Recruiting Testing the Effect of Raltegravir on Persistent de Novo HIV Infection in Virologic Responders to Antiretroviral Therapy
Condition: HIV-1 Infection
Intervention: Biological: HIV DNA
33 Recruiting Dutch Acute HCV in HIV Study (DAHHS-2): Grazoprevir/Elbasvir for Acute HCV
Conditions: Acute Hepatitis C;   Human Immunodeficiency Virus;   Hepatitis C
Intervention: Drug: Grazoprevir/Elbasvir 100mg/50mg
34 Not yet recruiting Pembrolizumab in Treating Patients With HIV and Relapsed, Refractory, or Disseminated Malignant Neoplasms
Conditions: AIDS-Related Non-Hodgkin Lymphoma;   Classical Hodgkin Lymphoma;   HIV Infection;   Kaposi Sarcoma;   Locally Advanced Malignant Neoplasm;   Metastatic Malignant Neoplasm;   Recurrent Hepatocellular Carcinoma;   Recurrent Hodgkin Lymphoma;   Recurrent Kaposi Sarcoma;   Recurrent Malignant Neoplasm;   Recurrent Melanoma;   Recurrent Melanoma of the Skin;   Recurrent Non-Hodgkin Lymphoma;   Recurrent Non-Small Cell Lung Carcinoma;   Refractory Hodgkin Lymphoma;   Refractory Malignant Neoplasm;   Solid Neoplasm;   Stage IIIA Hepatocellular Carcinoma;   Stage IIIA Non-Small Cell Lung Cancer;   Stage IIIA Skin Melanoma;   Stage IIIB Hepatocellular Carcinoma;   Stage IIIB Non-Small Cell Lung Cancer;   Stage IIIB Skin Melanoma;   Stage IIIC Hepatocellular Carcinoma;   Stage IIIC Skin Melanoma;   Stage IV Non-Small Cell Lung Cancer;   Stage IV Skin Melanoma;   Stage IVA Hepatocellular Carcinoma;   Stage IVB Hepatocellular Carcinoma
Interventions: Other: Laboratory Biomarker Analysis;   Biological: Pembrolizumab
35 Not yet recruiting Safety and Virologic Effect of a Human Monoclonal Antibody (VRC01) Administered Intravenously to Adults During Early Acute HIV Infection
Condition: HIV Infections
Interventions: Biological: VRC01;   Biological: Placebo for VRC01;   Drug: Antiretroviral therapy (ART) (regimen will vary within countries and by patient)
36 Completed Bioequivalence Study of Two Formulations With the Association of Tenofovir 300 mg and Emtricitabine 200 mg.
Condition: Acquired Immunodeficiency Syndrome
Intervention: Drug: Tenofovir disoproxil fumarate and emtricitabine
37 Completed A Study of Enfuvirtide (Fuzeon) in Participants With Advanced Human Immunodeficiency Virus (HIV) Infection
Condition: HIV Infections
Intervention: Drug: Enfuvirtide
38 Recruiting Vaginal Antibody Safety Trial: Safety Study of Monoclonal Antibodies to Reduce the Vaginal Transmission of Herpes Simplex Virus (HSV) and Human Immunodeficiency Virus (HIV)
Conditions: HIV;   Herpes Simplex Infections
Interventions: Drug: MB66;   Drug: Placebo Film
39 Recruiting Targeting Platelets in Chronic HIV Infection
Condition: HIV-1 Infection
Interventions: Drug: Clopidogrel;   Drug: Aspirin;   Drug: Placebo
40 Recruiting Antiviral Pharmacology and Adherence in Drug Users
Conditions: HEPATITIS C;   Virus, Human Immunodeficiency
Interventions: Behavioral: Directly Observed Therapy;   Behavioral: Wirelessly Observed Therapy

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years